TW201613934A - Methods for the preparation of 1,3-benzodioxole heterocyclic compounds - Google Patents

Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Info

Publication number
TW201613934A
TW201613934A TW104120096A TW104120096A TW201613934A TW 201613934 A TW201613934 A TW 201613934A TW 104120096 A TW104120096 A TW 104120096A TW 104120096 A TW104120096 A TW 104120096A TW 201613934 A TW201613934 A TW 201613934A
Authority
TW
Taiwan
Prior art keywords
preparation
heterocyclic compounds
methods
benzodioxole
benzodioxole heterocyclic
Prior art date
Application number
TW104120096A
Other languages
English (en)
Chinese (zh)
Inventor
Bjoern Metzler
Andre Faldt
Original Assignee
Leo Pharma As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharma As filed Critical Leo Pharma As
Publication of TW201613934A publication Critical patent/TW201613934A/zh

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/357Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having two or more oxygen atoms in the same ring, e.g. crown ethers, guanadrel
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/10Spiro-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Catalysts (AREA)
TW104120096A 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds TW201613934A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP14173397 2014-06-23

Publications (1)

Publication Number Publication Date
TW201613934A true TW201613934A (en) 2016-04-16

Family

ID=50980952

Family Applications (1)

Application Number Title Priority Date Filing Date
TW104120096A TW201613934A (en) 2014-06-23 2015-06-22 Methods for the preparation of 1,3-benzodioxole heterocyclic compounds

Country Status (18)

Country Link
US (1) US9908894B2 (enExample)
EP (1) EP3157930B1 (enExample)
JP (1) JP6785666B2 (enExample)
KR (1) KR20170016894A (enExample)
CN (1) CN106459081B (enExample)
AU (1) AU2015279428B2 (enExample)
BR (1) BR112016029510A2 (enExample)
CA (1) CA2953284A1 (enExample)
DK (1) DK3157930T3 (enExample)
ES (1) ES2702451T3 (enExample)
IL (1) IL249336A0 (enExample)
MX (1) MX2016016378A (enExample)
PL (1) PL3157930T3 (enExample)
PT (1) PT3157930T (enExample)
RU (1) RU2697251C2 (enExample)
TW (1) TW201613934A (enExample)
WO (1) WO2015197534A2 (enExample)
ZA (1) ZA201608442B (enExample)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI774791B (zh) * 2017-06-20 2022-08-21 丹麥商聯合醫療公司 1,3-苯并二氧雜環戊烯雜環化合物之製備方法

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX385592B (es) * 2015-12-18 2025-03-18 Union Therapeutics As Metodos para preparacion de compuestos heterociclicos de 1,3-benzodioxol.
DK3724196T3 (da) 2017-12-15 2023-01-16 Union Therapeutics As Substituerede azetidindihydrothienopyridiner og anvendelse deraf som phosphodiesterasehæmmere
USD914676S1 (en) 2018-05-11 2021-03-30 Samsung Electronics Co., Ltd. Notebook computer
NZ778223A (en) 2019-01-15 2024-11-29 Union Therapeutics As Modified release tablet formulations containing phosphodiesterase inhibitors
AU2022245186A1 (en) 2021-03-22 2023-10-05 UNION therapeutics A/S Treatment of hidradenitis suppurativa with orismilast
GB202205715D0 (en) 2022-04-19 2022-06-01 Union Therapeutics As Treatment of neutrophilic dermatoses
GB202306662D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Dosage regimen
GB202306663D0 (en) 2023-05-05 2023-06-21 Union Therapeutics As Combination therapy

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6514996B2 (en) * 1995-05-19 2003-02-04 Kyowa Hakko Kogyo Co., Ltd. Derivatives of benzofuran or benzodioxole
ATE325110T1 (de) * 1995-05-19 2006-06-15 Kyowa Hakko Kogyo Kk Sauerstoff enthaltende heterocyclische verbindungen
DE10205274A1 (de) * 2002-02-08 2003-08-21 Boehringer Ingelheim Pharma Neue Arzneimittelkompositionen enthaltend neben Anticholinergika heterocyclische Verbindungen
JPWO2004005276A1 (ja) * 2002-07-03 2005-11-04 協和醗酵工業株式会社 1,3−ベンゾジオキソール−2−スピロシクロアルカン誘導体の製造法
ATE496029T1 (de) * 2006-07-14 2011-02-15 Chiesi Farma Spa Derivate von 1-phenyl-2-pyridinylalkylenalkohole als phosphodiesteraseinhibitoren
DK2125736T3 (da) * 2006-12-22 2011-07-11 Leo Pharma As Substituerede acetophenoner egnede som PDE4-inhibitorer
PL2114951T3 (pl) * 2007-02-28 2014-10-31 Leo Pharma As Nowe inhibitory fosfodiesterazy
ZA200905371B (en) * 2007-02-28 2010-10-27 Leo Pharma As Novel phosphodiesterase Inhibitors
ES2733092T3 (es) * 2010-06-24 2019-11-27 Leo Pharma As Derivados de benzodioxol como inhibidores de la fosfodiesterasa
WO2014096018A1 (en) * 2012-12-19 2014-06-26 Leo Pharma A/S Methods for the preparation of substituted acetophenones
MX385592B (es) * 2015-12-18 2025-03-18 Union Therapeutics As Metodos para preparacion de compuestos heterociclicos de 1,3-benzodioxol.

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI774791B (zh) * 2017-06-20 2022-08-21 丹麥商聯合醫療公司 1,3-苯并二氧雜環戊烯雜環化合物之製備方法

Also Published As

Publication number Publication date
ES2702451T3 (es) 2019-03-01
JP2017520547A (ja) 2017-07-27
BR112016029510A2 (pt) 2017-08-22
WO2015197534A2 (en) 2015-12-30
MX2016016378A (es) 2017-10-16
IL249336A0 (en) 2017-02-28
PT3157930T (pt) 2018-12-24
AU2015279428A1 (en) 2017-01-05
PL3157930T3 (pl) 2019-04-30
RU2017101808A3 (enExample) 2019-01-22
EP3157930B1 (en) 2018-10-17
RU2017101808A (ru) 2018-07-27
EP3157930A2 (en) 2017-04-26
DK3157930T3 (en) 2019-01-21
AU2015279428B2 (en) 2018-02-15
CN106459081A (zh) 2017-02-22
US9908894B2 (en) 2018-03-06
ZA201608442B (en) 2018-05-30
RU2697251C2 (ru) 2019-08-13
KR20170016894A (ko) 2017-02-14
WO2015197534A3 (en) 2016-03-17
CA2953284A1 (en) 2015-12-30
JP6785666B2 (ja) 2020-11-18
CN106459081B (zh) 2019-09-10
US20170137438A1 (en) 2017-05-18

Similar Documents

Publication Publication Date Title
PH12018500718A1 (en) Compounds useful as modulators of trpm8
AU2015207757A8 (en) N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2
EA201792535A1 (ru) Гетероциклические амиды в качестве ингибиторов киназ
PH12017500408B1 (en) Heteroaryl compounds as btk inhibitors and uses thereof
HK1245019A1 (zh) 吡啶酰胺化合物作爲杀真菌剂的用途
PH12018500408A1 (en) Bicyclic compounds as atx inhibitors
PH12016501192B1 (en) Tetrahydropyridopyrazines modulators of gpr6
EA201692193A1 (ru) Способы получения ингибитора jak1 и его новых форм
MX2018001890A (es) Compuestos biciclicos como inhibidores de autotaxina (atx).
TW201613934A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
PH12016501941A1 (en) Use of heterocyclic compounds for controlling nematodes
MX2017008444A (es) Picolinamidas como fungicidas.
PH12018500409A1 (en) New bicyclic compounds as dual atx/ca inhibitors
NZ742952A (en) Methods for the preparation of 1,3-benzodioxole heterocyclic compounds
EA202091397A1 (ru) Бензохинолоновые ингибиторы vmat2
MX373320B (es) Compuestos inhibidores de pde2.
EA201790983A1 (ru) Синтез копанлисиба и его дигидрохлорида
MX394835B (es) Metodos para la preparacion de compuestos heterociclicos de 1,3-benzodioxol.
EA201790982A1 (ru) Синтез копанлисиба и его дигидрохлорида
PH12016501613B1 (en) Pyrazines modulators of gpr6
AU2015311730A8 (en) CaMKII inhibitors and uses thereof
MA39824A (fr) Composés azole amido-substitués
IN2015CH01182A (enExample)
BR112016027455A2 (pt) moduladores ppar
MX2017007380A (es) Compuestos organicos.